HPS Pharmacies wish to give notice that all suppliers of tamoxifen tablets are experiencing limited availability and supply interruptions as follows:
|Product||ARTG||Expected Return Date|
|Genox 10mg||40063||11th February 2020|
|Genox 20mg||40065||19th March 2020|
|Tamoxifen Sandoz 20mg||80076||5th March 2020|
|Tamosin 20mg||43527||10th February 2020|
|Nolvadex-D 20mg||11232||30th June 2020|
An internationally registered brand of tamoxifen 20mg tablets has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. Please note that Section 19A alternatives are subject to a longer lead time and different pricing as they must be sourced internationally.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates